Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor

Low-dose sunitinib monotherapy, with dosing intervals based on platelet counts, may be an effective treatment option for managing toxicity in older patients with imatinib-resistant GIST.

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2025-10-29
DOI
https://doi.org/10.21873/invivo.14167
Citations
1
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
1.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor

Midori Morita, Takuma Onoe, Koji Matsumoto, Hirotaka Suto et al.
1 citations
In Vivo
Gastrointestinal Tumor Research and Treatment
1.81
article

Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor

Midori Morita, Takuma Onoe, Koji Matsumoto, Hirotaka Suto, Hideki Sakai, Kyoko Ikeuchi, Miyuki Kawamura
article en
1 citations

Abstract

Low-dose sunitinib monotherapy, with dosing intervals based on platelet counts, may be an effective treatment option for managing toxicity in older patients with imatinib-resistant GIST.

In VivoVol. 39(6)
Hyogo Prefectural Cancer Center (JP)
Openalex Percentile: Top 12%
Gastrointestinal Tumor Research and Treatment
1.81
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.